Woodline Partners LP Syndax Pharmaceuticals Inc Transaction History

Woodline Partners LP

$19.5 Billion
Q3 2025

A detailed history of Woodline Partners LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Woodline Partners LP holds 1,550,520 shares of SNDX stock, worth $25.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,550,520

Previous 1,892,751 18.08%

Holding current value

$25.8 Million

Previous $17.7 Million 34.55%

% of portfolio

0.12%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$8.73 - $17.04 $2.99 Million - $5.83 Million	-342,231 Reduced 18.08%	1,550,520 $23.9 Million
Q2 2025 Aug 14, 2025	BUY	$8.9 - $14.15 $8,437 - $13,414	948 Added 0.05%	1,892,751 $17.7 Million
Q4 2024 Feb 14, 2025	SELL	$12.52 - $21.81 $52,947 - $92,234	-4,229 Reduced 0.22%	1,891,803 $25 Million
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $6.28 Million - $8.7 Million	350,504 Added 22.68%	1,896,032 $36.5 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $23,355 - $29,523	1,241 Added 0.08%	1,545,528 $31.7 Million

Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $1,399 - $1,744	71 Added 0.0%	1,544,287 $36.8 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $17.2 Million - $32.7 Million	1,510,149 Added 4432.88%	1,544,216 $33.4 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $8.4 Million - $12.6 Million	-578,249 Reduced 94.44%	34,067 $494,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $11.8 Million - $13.7 Million	612,316 New	612,316 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $14.6 Million - $19.6 Million	789,273 New	789,273 $19 Million
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $4.61 Million - $6.87 Million	-310,377 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $4.13 Million - $6.09 Million	-270,931 Reduced 46.61%	310,377 $6.79 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $5.18 Million - $7.4 Million	373,496 Added 179.73%	581,308 $11.1 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $2.79 Million - $5.23 Million	207,812 New	207,812 $3.57 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $1.5 Million - $1.91 Million	-77,699 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $1.17 Million - $2.05 Million	77,699 New	77,699 $1.73 Million

Others Institutions Holding SNDX

# of Institutions

253

Shares Held

99.8M

Call Options Held

1.41M

Put Options Held

737K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $940M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Syndax Pharmaceuticals Inc Transaction History